2026 data FDA MAUDE openFDA FDA Class II

Pump, Infusion, Insulin

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA Class II (moderate risk, special controls required), regulated under 21 CFR §880.5725 (General Hospital panel).

FDA MAUDE casebook

openFDA event book Pump, Infusion, Insulin HEAVY-BOOK · MAUDE

#7 of 1000 · 539,077 reports · 1992–2026

  • BOOK 539,077 reports
  • RANK #7 of 1000
  • DEATH 1,411 death-typed
  • INJ 96,050 injury-typed
  • MALF 439,826 malfunction
  • SPAN 1992–2026
  • PEAK 2015: 69,136
  • PHOTO Automated Insulin Dos…

Nearest event-volume peer: Automated Insulin Dosing , Threshold Suspend (99,679 report gap)

Pump, Infusion, Insulin sits #7 of 1000 among tracked device types with 539,077 MAUDE reports spanning 1992–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Malfunction reports run above the device-type norm

Pump, Infusion, Insulin carries 81.6% MALFUNCTION-coded reports, 16.8pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 0.3% corpus 1.5% · below corpus mean (-1.2 pp)
  • INJ 17.8% corpus 30.3% · below corpus mean (-12.5 pp)
  • MALF 81.6% corpus 64.8% · above corpus mean (+16.8 pp)

Lead product-problem code Unintended Movement is 10% of coded problems · Lead manufacturer ANIMAS CORPORATION accounts for 31% of manufacturer-tagged reports · Top event location is 48% of location-tagged rows .

Pump, Infusion, Insulin in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Pump, Infusion, Insulin carries 539,077 MAUDE reports, ranked #7 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 439,826 (81.6%)
Injury 96,050 (17.8%)
Death 1,411 (0.3%)
1,068 (0.2%)
Other 722 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

443,245 (79.7%)
Hospitalization 41,490 (7.5%)
Other 31,532 (5.7%)
R 12,593 (2.3%)
Required Intervention 11,096 (2.0%)
Life Threatening 9,767 (1.8%)
L 2,810 (0.5%)
Death 1,413 (0.3%)
O 1,055 (0.2%)
H 637 (0.1%)
S 114 (0.0%)
Disability 65 (0.0%)
Congenital Anomaly 11 (0.0%)
D 8 (0.0%)
Invalid Data 1 (0.0%)

Top Product Problems

Unintended Movement 40,578
Device Displays Incorrect Message 36,684
Material Twisted/Bent 34,765
Insufficient Device Problem Information 26,674
Device Operates Differently Than Expected 25,564
Loss of or Failure to Bond 24,656
Pumping Stopped 20,976
Crack 20,309
Poor Quality Image 20,004
Mechanical Problem 19,076
Adverse Event Without Identified Device or Use Problem 18,084
No Display/Image 16,755
Break 15,489
Failure to Prime 14,356
Device Inoperable 14,249
Battery Problem 12,542
Difficult or Delayed Activation 11,795
Fluid/Blood Leak 11,746
Incorrect Measurement 11,718
Failure to Fire 11,622

Yearly Trend

92
1992: 4
93
1993: 1
94
1994: 7
95
1995: 6
96
1996: 61
97
1997: 170
98
1998: 204
99
1999: 294
00
2000: 341
01
2001: 598
02
2002: 1,001
03
2003: 2,105
04
2004: 3,299
05
2005: 3,209
06
2006: 4,099
07
2007: 5,110
08
2008: 5,711
09
2009: 9,471
10
2010: 10,174
11
2011: 12,854
12
2012: 18,365
13
2013: 30,055
14
2014: 49,181
15
2015: 69,136
16
2016: 56,584
17
2017: 44,472
18
2018: 32,652
19
2019: 29,027
20
2020: 32,588
21
2021: 31,522
22
2022: 28,225
23
2023: 21,972
24
2024: 18,228
25
2025: 12,151
26
2026: 6,200

Reports fell to 12,151 in 2025, down from an average of 20,100 in the two years before.

Related Entities for Pump, Infusion, Insulin

Event Locations

260,074 (48.2%)
I 254,925 (47.3%)
OTHER 10,974 (2.0%)
HOME 4,727 (0.9%)
NOT APPLICABLE 2,965 (0.6%)
U 2,918 (0.5%)
NO INFORMATION 2,009 (0.4%)
HOSPITAL 150 (0.0%)
UNKNOWN 148 (0.0%)
INVALID DATA 96 (0.0%)
SCHOOL 35 (0.0%)
OUTPATIENT TREATMENT FACILITY 10 (0.0%)
LABORATORY 9 (0.0%)
OUTDOORS 9 (0.0%)
CLINIC - WALK IN, OTHER 6 (0.0%)
OUTPATIENT DIAGNOSTIC FACILITY 6 (0.0%)
PUBLIC VENUE 4 (0.0%)
NURSING HOME 3 (0.0%)
PUBLIC BUILDING 2 (0.0%)
REHABILITATION CENTER 2 (0.0%)
STREET 2 (0.0%)
AMBULATORY HEALTH CARE FACILITY 1 (0.0%)
AMBULATORY SURGICAL FACILITY 1 (0.0%)
PARK 1 (0.0%)

Compare ANIMAS CORPORATION vs INSULET CORPORATION →

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Pump, Infusion, Insulin: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (539,077 here).

Similar death-typed counts

Nearest other device types by death-typed report count (1,411 here), distinct from the volume row.

Disclaimer: MAUDE figures for Pump, Infusion, Insulin are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Pump, Infusion, Insulin; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.